Close Menu

NEW YORK (360Dx) – T2 Biosystems announced today that its has filed a 510(k) premarket submission for its T2Bacteria Panel with the US Food and Drug Administration.

The panel runs on the FDA-cleared T2Dx instrument and is designed to be a comprehensive rapid diagnostic test that identifies pathogens associated with sepsis within hours instead of days, T2 Biosystems said.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Mar
20
Sponsored by
Qiagen

This webinar will discuss how a new multiplexed testing system can help physicians rapidly diagnose acute respiratory infections in the near-patient setting.

Mar
21
Sponsored by
Loop Genomics

This webinar provides a comparison of next-generation sequencing (NGS) approaches for human transcriptome sequencing, including short-read Illumina sequencing and synthetic long-read sequencing technology.

Mar
26
Sponsored by
PerkinElmer

This webinar will address the current status and future directions for massively high-throughput genomics for plant and animal breeding and research.

Mar
27
Sponsored by
Swift Biosciences

Sequencing workflows require library quantification and normalization to ensure data quality and reduce cost.